Target intelligence / Profile preview

Plasmodium apicoplast ribosome

Molecular classification
Ribonucleoprotein complex, Ribosome, Other
01

Overview

The Plasmodium apicoplast ribosome is a prokaryotic-like 70S ribosome located within the apicoplast, a non-photosynthetic plastid essential for the survival of malaria parasites (Goodman et al., 2007, "Antibiotics, the apicoplast and malaria"). This organelle is derived from an ancient secondary endosymbiosis and contains its own vestigial genome, which encodes components of the translation machinery (Wilson et al., 2015, "The apicoplast and its ribosome"). The apicoplast ribosome is responsible for synthesizing essential proteins required for the maintenance of the organelle and its metabolic functions, such as the synthesis of isoprenoid precursors like isopentenyl pyrophosphate (Dahl & Rosenthal, 2007, "Multiple antibiotics that inhibit the Plasmodium falciparum apicoplast"). Because of its bacterial origins, the apicoplast ribosome is highly susceptible to various classes of antibiotics that do not affect the host's eukaryotic 80S ribosomes, making it an ideal therapeutic target (Botté et al., 2012, "Apicoplast: a central hub for lipid organelles"). Drugs targeting this ribosome, such as doxycycline and clindamycin, typically exhibit a "delayed death" phenotype, where the parasite's growth is not immediately halted but the subsequent generation of parasites fails to develop (Kennedy et al., 2019, "Delayed death in the malaria parasite"). This target remains a cornerstone in the treatment of multidrug-resistant malaria and the development of prophylactic strategies.

Other names
Apicoplast 70S ribosomePlasmodium falciparum apicoplast ribosomePlastid ribosomeApicoplast translation machinery
02

Mechanism of action

Inhibition of protein translation within the apicoplast organelle, leading to the disruption of essential metabolic pathways and the delayed death of the parasite.

03

Biological functions

Protein synthesisTranslationOrganelle maintenanceIsoprenoid biosynthesisOther
04

Disease associations

InfectionMalaria
05

Safety considerations

Delayed onset of actionAntibiotic resistancePhotosensitivityGastrointestinal distressContraindication in pregnancy (certain antibiotics)
06

Interacting drugs

Doxycycline

6 more in the full profile.

07

Biomarkers

ParasitemiaApicoplast-to-nuclear DNA ratioApicoplast protein expression levels

Beyond the preview

Go deeper on Plasmodium apicoplast ribosome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium apicoplast ribosome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call